FAIM
CVS icon

Financial Advocates Investment Management’s CVS Health CVS Stock Holding History

Financial Advocates Investment Management’s Portfolio CVS Stock Details CVS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-3,851
Closed -$307K – 754
2024
Q1 		$307K Sell
3,851
-622
-14% -$47.5K 0.02% 582
2023
Q4 		$353K Sell
4,473
-2,042
-31% -$145K 0.02% 506
2023
Q3 		$455K Buy
6,515
+110
+2% +$7.79K 0.03% 436
2023
Q2 		$443K Sell
6,405
-1,018
-14% -$72.4K 0.03% 432
2023
Q1 		$552K Sell
7,423
-1,853
-20% -$155K 0.04% 410
2022
Q4 		$864K Buy
9,276
+1,309
+16% +$126K 0.06% 321
2022
Q3 		$758K Sell
7,967
-17,306
-68% -$1.71M 0.06% 314
2022
Q2 		$2.34M Sell
25,273
-500
-2% -$48.8K 0.19% 133
2022
Q1 		$2.61M Buy
25,773
+14,073
+120% +$1.48M 0.17% 140
2021
Q4 		$1.21M Buy
11,700
+182
+2% +$16.8K 0.08% 292
2021
Q3 		$977K Buy
11,518
+2,302
+25% +$193K 0.07% 321
2021
Q2 		$769K Buy
9,216
+1,607
+21% +$132K 0.05% 375
2021
Q1 		$572K Buy
7,609
+260
+4% +$18.9K 0.04% 452
2020
Q4 		$502K Buy
7,349
+1,020
+16% +$66.3K 0.03% 448
2020
Q3 		$369K Buy
6,329
+103
+2% +$6.41K 0.03% 429
2020
Q2 		$405K Sell
6,226
-2,983
-32% -$188K 0.04% 397
2020
Q1 		$547K Sell
9,209
-4,490
-33% -$300K 0.08% 261
2019
Q4 		$1.02M Sell
13,699
-890
-6% -$62.5K 0.11% 207
2019
Q3 		$920K Buy
14,589
+3,095
+27% +$183K 0.11% 198
2019
Q2 		$627K Sell
11,494
-1,546
-12% -$83.3K 0.07% 248
2019
Q1 		$703K Buy
13,040
+6,302
+94% +$389K 0.09% 220
2018
Q4 		$442K Buy
6,738
+559
+9% +$41.7K 0.06% 267
2018
Q3 		$486K Sell
6,179
-545
-8% -$39K 0.05% 290
2018
Q2 		$438K Sell
6,724
-3,222
-32% -$212K 0.05% 285
2018
Q1 		$619K Sell
9,946
-3,906
-28% -$280K 0.08% 226
2017
Q4 		$1M Buy
+13,852
New +$1.01M 0.14% 159

Other funds holding CVS

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

Financial Advocates Investment Management's CVS Position: Q2 2024 in Review

Financial Advocates Investment Management sold out of CVS Health (CVS) in Q2 2024, closing a stake of 3,851 shares — an estimated $307K sold.

Financial Advocates Investment Management first reported a position in CVS in Q4 2017 and held it in 26 quarters. The position peaked at $2.61M in Q1 2022. 1,912 funds tracked by Wall St. Rank hold CVS as of Q2 2024.

  • Financial Advocates Investment Management reported no remaining CVS Health position as of Q2 2024 after selling out during the quarter.
  • Financial Advocates Investment Management sold 3,851 CVS Health shares in Q2 2024, an estimated $307K.
  • Financial Advocates Investment Management first reported a position in CVS Health in Q4 2017 and held it in 26 quarters.
  • Financial Advocates Investment Management's CVS Health position peaked at $2.61M in Q1 2022.
  • 1,912 funds tracked by Wall St. Rank held CVS Health as of Q2 2024.

Based on Financial Advocates Investment Management's 13F filing for Q2 2024, filed 29 Jul 2024.